Euformatics supports the rare disease science challenge BeHEARD 2015
Euformatics is happy to support the annual rare disease BeHEARD science challenge. BeHEARD brings together dedicated partners from academia and
Euformatics at ESHG 2015
Euformatics is present at European Society of Human Genetics meeting 2015 on June 6-9 at Glasgow, booth #528. On the agenda: Release
Euformatics and BC|Platforms enter into partnership
A strategic co-operation agreement was signed between two bioinformatics companies to introduce a more efficient solution for the analysis of
Genetic testing must cope with biological complexity
The medication landscape is constantly changing, in particular the cancer medication landscape. A strong emphasis on cancer research has yielded
NextSeq 500: high-throughput desktop sequencer for clinical use
At the beginning of new year 2014 Illumina, Inc. presented two new instruments to its clients. First novelty is a NextSeq 500 desktop sequencer
NGS in clinical diagnostics, whole exome or targeted sequencing?
Next-generation sequencing is coming to clinical diagnostics, but which one is more suitable for clinicians, whole exome or targeted sequencing? The